Page 1

( Mark One ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D.C. 20549 FORM 20 - F ☑ ☐ ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12 ( b ) OR ( g ) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from OR to SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report Commission File Number 001-39084 Innate Pharma SA ( Exact name of registrant as specified in its charter and translation of registrant's name into English ) France ( Jurisdiction of incorporation or organization ) 117 , Avenue de Luminy 13009 Marseille France ( Address of principal executive offices ) Mondher Mahjoubi , M.D. Chairman and Chief Executive Officer Innate Pharma S.A. 117 Avenue de Luminy 13009 Marseille France Tel : +33 4 30 30 30 30 ( Name , Telephone , E - mail and / or Facsimile number and Address of Company Contact Person ) Securities registered or to be registered pursuant to Section 12 ( b ) of the Act . Title of each class American Depositary Shares , each representing one ordinary share , nominal value € 0.05 per share Ordinary shares , nominal value € 0.05 per share Trading Symbol IPHA * * Not for trading , but only in connection with the registration of the American Depositary Shares . Name of each exchange on which registered The Nasdaq Global Select Market The Nasdaq Global Select Market * Securities registered or to be registered pursuant to Section 12 ( g ) of the Act . None Securities for which there is a reporting obligation pursuant to Section 15 ( d ) of the Act . Non Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report . Ordinary shares , nominal value € 0.05 per share : 78,986,490 as of December 31 , 2020 Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . ☐ Yes No If this report is an annual or transition report , indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15 ( d ) of the Securities Exchange Act of 1934. ☐ Yes > No